These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 28782296)

  • 1. Combining anti-IgE with oral immunotherapy.
    Lin C; Lee IT; Sampath V; Dinakar C; DeKruyff RH; Schneider LC; Nadeau KC
    Pediatr Allergy Immunol; 2017 Nov; 28(7):619-627. PubMed ID: 28782296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral immunotherapy and potential treatment.
    Sato S; Yanagida N; Ebisawa M
    Chem Immunol Allergy; 2015; 101():106-13. PubMed ID: 26022870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Use of Omalizumab in Food Oral Immunotherapy.
    Labrosse R; Graham F; Des Roches A; Bégin P
    Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):189-199. PubMed ID: 27628022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral immunotherapy and anti-IgE antibody-adjunctive treatment for food allergy.
    Nadeau KC; Kohli A; Iyengar S; DeKruyff RH; Umetsu DT
    Immunol Allergy Clin North Am; 2012 Feb; 32(1):111-33. PubMed ID: 22244236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy in food allergy: towards new strategies.
    Sato S; Yanagida N; Ogura K; Asaumi T; Okada Y; Koike Y; Iikura K; Syukuya A; Ebisawa M
    Asian Pac J Allergy Immunol; 2014 Sep; 32(3):195-202. PubMed ID: 25268336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical aspects of oral immunotherapy for the treatment of allergies.
    Yanagida N; Sato S; Ebisawa M
    Semin Immunol; 2017 Apr; 30():45-51. PubMed ID: 28780220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy.
    Frischmeyer-Guerrerio PA; Masilamani M; Gu W; Brittain E; Wood R; Kim J; Nadeau K; Jarvinen KM; Grishin A; Lindblad R; Sampson HA
    J Allergy Clin Immunol; 2017 Oct; 140(4):1043-1053.e8. PubMed ID: 28414061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining Anti-IgE Monoclonal Antibodies and Oral Immunotherapy for the Treatment of Food Allergy.
    Guilleminault L; Michelet M; Reber LL
    Clin Rev Allergy Immunol; 2022 Feb; 62(1):216-231. PubMed ID: 34550555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Immunotherapy for Food Allergy.
    Wood RA
    J Investig Allergol Clin Immunol; 2017; 27(3):151-159. PubMed ID: 28102823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy.
    Wood RA; Kim JS; Lindblad R; Nadeau K; Henning AK; Dawson P; Plaut M; Sampson HA
    J Allergy Clin Immunol; 2016 Apr; 137(4):1103-1110.e11. PubMed ID: 26581915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical studies in oral allergen-specific immunotherapy: differences among allergens.
    Sato S; Yanagida N; Ogura K; Imai T; Utsunomiya T; Iikura K; Goto M; Asaumi T; Okada Y; Koike Y; Syukuya A; Ebisawa M
    Int Arch Allergy Immunol; 2014; 164(1):1-9. PubMed ID: 24943470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omalizumab in children with severe allergic disease: a case series.
    Crisafulli G; Caminiti L; Chiera F; Arasi S; Salzano G; Panasiti I; Barbalace A; Pajno GB
    Ital J Pediatr; 2019 Jan; 45(1):13. PubMed ID: 30642367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Outcome of Peanut Oral Immunotherapy Facilitated Initially by Omalizumab.
    Yee CSK; Albuhairi S; Noh E; El-Khoury K; Rezaei S; Abdel-Gadir A; Umetsu DT; Burke-Roberts E; LeBovidge J; Schneider L; Rachid R
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):451-461.e7. PubMed ID: 30267889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Options for the Treatment of Food Allergy.
    Lanser BJ; Wright BL; Orgel KA; Vickery BP; Fleischer DM
    Pediatr Clin North Am; 2015 Dec; 62(6):1531-49. PubMed ID: 26456449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Food allergy-From food avoidance to active treatment.
    Costa C; Coimbra A; Vítor A; Aguiar R; Ferreira AL; Todo-Bom A
    Scand J Immunol; 2020 Jan; 91(1):e12824. PubMed ID: 31486118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy.
    Scurlock AM
    Clin Rev Allergy Immunol; 2018 Oct; 55(2):139-152. PubMed ID: 29656306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omalizumab in IgE-Mediated Food Allergy: A Systematic Review and Meta-Analysis.
    Zuberbier T; Wood RA; Bindslev-Jensen C; Fiocchi A; Chinthrajah RS; Worm M; Deschildre A; Fernandez-Rivas M; Santos AF; Jaumont X; Tassinari P
    J Allergy Clin Immunol Pract; 2023 Apr; 11(4):1134-1146. PubMed ID: 36529441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant Therapies in Food Immunotherapy.
    Loh W; Tang M
    Immunol Allergy Clin North Am; 2018 Feb; 38(1):89-101. PubMed ID: 29132677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for Food Allergy: Are We There Yet?
    Gernez Y; Nowak-Węgrzyn A
    J Allergy Clin Immunol Pract; 2017; 5(2):250-272. PubMed ID: 28283151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing the Safety and Efficacy of Food Allergy Immunotherapy: a Review of Adjunctive Therapies.
    Virkud YV; Wang J; Shreffler WG
    Clin Rev Allergy Immunol; 2018 Oct; 55(2):172-189. PubMed ID: 29968170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.